Access to anti-retroviral drugs, female in Montenegro

Montenegro: Access to anti-retroviral drugs, female was 65.0% in 2024. ▲ Rising

Latest (2024)
65.0%
Change on year
up 10.2%
World rank
91st
of 141 countries
All-time high
65.0%
in 2024
All-time low
10.0%
in 2003
Years of data
25
2000–2024

Access to anti-retroviral drugs, female in Montenegro, 2000–2024

02040602000201220242000: 13 %2001: 12 %2002: 11 %2003: 10 %2004: 27 %2005: 24 %2006: 21 %2007: 26 %2008: 29 %2009: 26 %2010: 23 %2011: 21 %2012: 23 %2013: 25 %2014: 33 %2015: 34 %2016: 37 %2017: 40 %2018: 45 %2019: 49 %2020: 44 %2021: 40 %2022: 44 %2023: 59 %2024: 65 %

Source: UNAIDS estimates. Measured in %.

Analysis

In 2024, access to anti-retroviral drugs, female in Montenegro stood at 65.0%. That is the highest value across all 25 years on record.

The figure is up 10.2% on the previous year and up 97.0% over ten years.

Over the whole period, access to anti-retroviral drugs, female in Montenegro peaked at 65.0% in 2024 and was at its lowest, 10.0%, in 2003.

That places Montenegro 91st out of 141 countries with data for 2024, putting it in the middle of the range.

The long-run direction has been consistently rising across the 25 years of available data.

Access to anti-retroviral drugs, female in Montenegro, year by year

Annual values for Access to anti-retroviral drugs, female (%) in Montenegro, 2000 to 2024.
Year % Change
2000 13.0%
2001 12.0% -7.7%
2002 11.0% -8.3%
2003 10.0% -9.1%
2004 27.0% +170.0%
2005 24.0% -11.1%
2006 21.0% -12.5%
2007 26.0% +23.8%
2008 29.0% +11.5%
2009 26.0% -10.3%
2010 23.0% -11.5%
2011 21.0% -8.7%
2012 23.0% +9.5%
2013 25.0% +8.7%
2014 33.0% +32.0%
2015 34.0% +3.0%
2016 37.0% +8.8%
2017 40.0% +8.1%
2018 45.0% +12.5%
2019 49.0% +8.9%
2020 44.0% -10.2%
2021 40.0% -9.1%
2022 44.0% +10.0%
2023 59.0% +34.1%
2024 65.0% +10.2%

Averages by decade

DecadeAverage LowestHighest Years
2000s 19.9% 10.0% 29.0% 10
2010s 33.0% 21.0% 49.0% 10
2020s 50.4% 40.0% 65.0% 5

Countries ranked near Montenegro

  1. 88 Barbados 67.0% compare
  2. 88 Iraq 67.0% compare
  3. 88 Jordan 67.0% compare
  4. 91 Algeria 65.0% compare
  5. 91 Costa Rica 65.0% compare
  6. 91 Malaysia 65.0% compare

See the full ranking of 160 places →

More gender data for Montenegro

All data for Montenegro →

Frequently asked questions

What is access to anti-retroviral drugs, female in Montenegro?
Access to anti-retroviral drugs, female in Montenegro was 65.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, female recorded in Montenegro?
The highest recorded value was 65.0% in 2024.
What is the lowest access to anti-retroviral drugs, female recorded in Montenegro?
The lowest recorded value was 10.0% in 2003.
How does Montenegro rank for access to anti-retroviral drugs, female?
Montenegro ranks 91st out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, female rising or falling in Montenegro?
Over the last ten years it is up 97.0%. The long-run trend across the full record is rising.
Where does this Montenegro data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, female in Montenegro. Statizoid, drawing on UNAIDS estimates. Retrieved 09 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-female-percent/montenegro/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-female-percent/montenegro/">Access to anti-retroviral drugs, female in Montenegro</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, female (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,925 data points, 2000–2024
Last refreshed

The percentage of adult females living with HIV who are receiving antiretroviral therapy.